Insider · CIK 0001849236
Clare Kahn
director
Files at SLDB (Solid Biosciences Inc.). First filing Mar 13, 2025, latest Mar 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$9,924 bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SLDB: Solid Biosciences Inc.
SLDBOct 9, 2026 · close 6.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | SLDBbuy Solid Biosciences Inc. | $9,924 1,860 shares | +169% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +77,500 | $0.00 | $0 | 77,500 | Jun 13, 2025 |
| Mar 11, 2025 | SLDB Solid Biosciences Inc. | POpen-market purchase Common Stock | +1,860 | $5.34 | $9,924 | 2,960 | Mar 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.